Rheumatology

A study of the adult Korean population found high salt intake was associated with an increase in major adverse cardiovascular events (MACE) in patients with rheumatoid arthritis (RA).

Secukinumab is approved for use among patients with enthesitis-related arthritis (ERA) aged 4 years and up, and those with psoriatic arthritis (PsA) who are at least 2 years old.

Stacy Courtnay is the community network chair for the Arthritis Foundation in Atlanta highlights a report that discusses how understanding patient experiences in RA can shift questions researchers ask.

With a low number of approved medications for pediatric plaque psoriasis, secukinumab is a valuable new addition to the limited treatment options available.

Study investigators saw sustained clinical response regardless of whether the participant with rheumatoid arthritis (RA) had discontinued the first tumor necrosis factor inhibitor (TNFi) due to a primary or secondary inefficacy.

Limited access to exercise equipment and facilities during lockdown appears to be a key reason for reduced physical activity levels.

Interstitial lung disease (ILD), created by inflammation that leads to scarring of the lungs, causes shortness of breath, dry cough, and fatigue; data show it doubles mortality risk in rheumatoid arthritis (RA).

Circulating Interleukin-11 is difficult to detect in healthy individuals, but when it is present in various inflammatory diseases, it has an elevated present in affected tissues, according to a literature review.

New research found that residual inflammation in ultrasound images was associated with patient-reported outcomes (PROs) in patients with rheumatoid arthritis (RA) with low disease activity, but not in patients in remission.

A new sub-analysis suggested eating foods with anti-inflammatory properties may improve physical functioning in patients with rheumatoid arthritis.

Abstracts from American College of Rheumatology Convergence 2021 showed whether gender can impact the effectiveness of secukinumab in patients with ankylosing spondylitis (AS) or psoriatic arthritis (PsA).

Data outline prevalence of COVID-19 breakthrough and long haul infections among patients with rheumatic diseases.

Biological markers collected early in the disease course of rheumatoid arthritis could help improve patient management, researchers said.

If FDA approved for children, secukinumab (Cosentyx) will be the first biologic treatment for children in the US living with enthesitis-related arthritis.

The most common health care disruption found in the study was the replacement of face-to-face consultations with over-the-phone appointments.

The review found an association between systemic inflammatory disorders and increased risk of cardiovascular disease, encouraging discussions with patients regarding statin therapy.

Most early glucocorticoid treatment was targeted to patients with the most severe or active disease, according to study results from Canada.

Patients with axial spondyloarthritis treated with secukinumab achieved a reduction in spinal pain and improved disease activity measures early in treatment.

Researchers hope these findings help develop methods to assess cognitive function in patients with rheumatoid arthritis.

A new opinion piece makes the case that rheumatoid arthritis care can, and should, be better tailored to individual case characteristics.

Results of a pooled analysis showed patients with rheumatoid arthritis who take upadacitinib may be at increased risk of herpes zoster.

Three-quarters of patients said they were worried about the risks associated with SARS-CoV-2 infection.

Duration of rheumatoid arthritis and use of corticosteroids were associated with higher risk of adverse outcomes following coronary artery bypass graft (CABG).

Patients with rheumatoid arthritis (RA) who suffer from malnutrition were more likely to be frail and face mental health challenges.

A look at the existing literature suggests more questions than answers remain when it comes to the potential use of the cholinergic anti-inflammatory pathway in connective tissue diseases (CTDs).

The reports suggest patients with rheumatoid arthritis (RA) could experience secondary neurological adverse events, though the side effect appears to be rare.

Patients with rheumatoid arthritis (RA) who used tumor necrosis factor (TNF) inhibitors had significantly higher rates of nonmelanoma skin cancer and non-Hodgkin lymphoma.

A new study lends insights into the prevalence of lung abnormalities in patients with newly diagnosed cases of rheumatoid arthritis (RA).

In pediatric patients with frequently relapsing nephrotic syndrome (FRNS), the therapy was well tolerated, but did not lead to significant changes in disease course.

The new study, based on an analysis of existing literature and a replication cohort, helps clarify the role of a variant in microRNA-146a.